Stock comparison
AbbVie Inc. is 1.7x more valuable than Novartis AG by market capitalization ($510.74 B vs $309.21 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ABBV is larger
AbbVie Inc. is 1.7x more valuable than Novartis AG by market capitalization ($510.74 B vs $309.21 B).
Market value leader
ABBV
AbbVie Inc. is 1.7x more valuable than Novartis AG by market capitalization ($510.74 B vs $309.21 B).
| Metric | ABBV | NVS |
|---|---|---|
| Market cap | $510.74 B | $309.21 B |
| US-listed rank | #21 | #38 |
| Revenue (latest FY) | $61.16B | - |
| Net income (latest FY) | $4.23B | - |
| Net margin | 6.9% | - |
| P/E (trailing FY) | 120.9x | - |
| SEC filings | 1,008 | 953 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AbbVie Inc. is 1.7x more valuable than Novartis AG by market capitalization ($510.74 B vs $309.21 B).
Full pages: AbbVie Inc. and Novartis AG, or browse the full rankings.